A new therapy shows promise for patients with mild idiopathic pulmonary fibrosis. According to researchers in Japan, inhaled N-acetylcysteine (NAC) monotherapy preserves more lung function in some idiopathic pulmonary fibrosis (IPF) patients than no therapy.
Copyright 2009 Health & Leisure All RIghts Reserved
9th Floor Ayala Life-FGU Center, 6811 Ayala Avenue Makati City
Philippines: +632.813 4527 United States: +1.818.748.8735 firstname.lastname@example.org